Literature DB >> 24878550

Atypical ulnar fracture associated with long-term bisphosphonate use.

Ryusuke Osada1, Mineyuki Zukawa2, Tomoatsu Kimura2.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24878550     DOI: 10.1007/s00776-014-0589-0

Source DB:  PubMed          Journal:  J Orthop Sci        ISSN: 0949-2658            Impact factor:   1.601


× No keyword cloud information.
  5 in total

Review 1.  Ulnar fractures with bisphosphonate therapy: a systematic review of published case reports.

Authors:  S H S Tan; S Saseendar; B H M Tan; A Pawaskar; V P Kumar
Journal:  Osteoporos Int       Date:  2014-09-17       Impact factor: 4.507

2.  Treatment of Atypical Ulnar Fractures Associated with Long-Term Bisphosphonate Therapy for Osteoporosis: Autogenous Bone Graft with Internal Fixation.

Authors:  Yohei Shimada; Tetsuhiro Ishikawa; Jun Endo; Jo Katsuragi; Toshiaki Kotani; Hitoshi Kiuchi; Kazuki Kuniyoshi; Seiji Ohtori
Journal:  Case Rep Orthop       Date:  2017-11-29

3.  Treatment of Atypical Fracture of the Ulnar Diaphysis by Open Reduction and Internal Fixation with Teriparatide.

Authors:  Hiroki Ito; Naohisa Miyakoshi; Yuji Kasukawa; Takeshi Sato; Hitoshi Kubota; Hiroshi Sasaki; Takashi Mizutani; Yoichi Shimada
Journal:  Case Rep Orthop       Date:  2019-09-04

Review 4.  Treatment strategy for atypical ulnar fracture due to severely suppressed bone turnover caused by long-term bisphosphonate therapy: a case report and literature review.

Authors:  Kensaku Abe; Hiroaki Kimura; Norio Yamamoto; Shingo Shimozaki; Takashi Higuchi; Yuta Taniguchi; Takaaki Uto; Hiroyuki Tsuchiya
Journal:  BMC Musculoskelet Disord       Date:  2020-12-03       Impact factor: 2.362

5.  Medical Management of Patients After Atypical Femur Fractures: a Systematic Review and Recommendations From the European Calcified Tissue Society.

Authors:  Denise M van de Laarschot; Malachi J McKenna; Bo Abrahamsen; Bente Langdahl; Martine Cohen-Solal; Núria Guañabens; Richard Eastell; Stuart H Ralston; M Carola Zillikens
Journal:  J Clin Endocrinol Metab       Date:  2020-05-01       Impact factor: 5.958

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.